In Vivo Investigation of Novel Nano-vesicles of Salbutamol Sulphate

NCT03059017 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Drug Effect
Pulmonary Disease

Interventions

DRUG: Salbutamol Sulphate
DRUG: Niosomes

Sponsor

British University In Egypt